Published in Int J Pharm on March 12, 2007
Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines (2012) 1.44
Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. Saudi Pharm J (2011) 0.92
Increased emperipolesis in megakaryocytes in a case of idiopathic thrombocytopenic purpura. Indian J Pathol Microbiol (2006) 2.07
Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst (2013) 1.45
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm (2001) 1.22
Ophthalmoscopic abnormalities in adults with falciparum malaria. QJM (1998) 1.17
Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol (2011) 1.13
Microfilariae in bone marrow aspiration smears, correlation with marrow hypoplasia: a report of six cases. Indian J Pathol Microbiol (2006) 1.09
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine (2008) 1.08
Prognostic significance of eye changes in cerebral malaria. J Assoc Physicians India (2000) 1.08
Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target (2004) 1.03
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm (2003) 1.03
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm (2011) 1.02
Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm (2000) 0.97
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms. J Immunol (2011) 0.96
Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine (2008) 0.96
Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J (2010) 0.96
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target (2007) 0.95
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm (2007) 0.95
Release kinetic studies of aspirin microcapsules from ethyl cellulose, cellulose acetate phthalate and their mixtures by emulsion solvent evaporation method. Sci Pharm (2009) 0.94
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm (2005) 0.93
Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol (2013) 0.93
Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst (2006) 0.93
Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res (2010) 0.91
Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des (2009) 0.89
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release (2009) 0.88
Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharm Sci (2001) 0.88
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol (2011) 0.88
Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension. J Pharm Sci (2010) 0.87
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target (2006) 0.87
Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev Ind Pharm (1998) 0.87
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci (2008) 0.87
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance. Expert Opin Drug Deliv (2013) 0.87
pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie (2002) 0.86
Biomaterial-based scaffolds--current status and future directions. Expert Opin Drug Deliv (2014) 0.85
Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol (2012) 0.85
Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies. Pharmazie (2000) 0.84
Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Rev Vaccines (2007) 0.84
Dieulafoy disease of the stomach presenting as mass lesion--a case report. Indian J Pathol Microbiol (2005) 0.83
Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.83
Polysaccharide coated liposomes for oral immunization--development and characterization. Int J Pharm (2000) 0.83
The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol (2000) 0.83
Primary extramedullary solitary plasmacytoma of conjunctiva--a case report. Indian J Ophthalmol (1985) 0.82
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Curr Cancer Drug Targets (2010) 0.82
Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. Int J Pharm (2005) 0.82
Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India. Asian Pac J Allergy Immunol (2012) 0.82
Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol (2005) 0.82
Teaching neuroImages: Griscelli syndrome and CNS lymphohistiocytosis. Neurology (2014) 0.82
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett (2005) 0.82
Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm (2011) 0.81
siRNA delivery using nanocarriers - an efficient tool for gene silencing. Curr Gene Ther (2010) 0.81
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Control Release (2009) 0.81
Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. J Drug Target (2010) 0.81
Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharm Res (2001) 0.80
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm (2010) 0.80
Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm (2004) 0.80
Localized rifampicin albumin microspheres. J Microencapsul (1991) 0.80
Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul (1996) 0.80
Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target (2011) 0.80
Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting. Curr Mol Med (2013) 0.80
Proliposomes of indomethacin for oral administration. J Microencapsul (1991) 0.80
Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study. Pharm Acta Helv (2000) 0.80
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine (2011) 0.80
Topical liposome system bearing local anaesthetic lignocaine: preparation and evaluation. J Microencapsul (1994) 0.79
Gel core liposomes: an advanced carrier for improved vaccine delivery. J Microencapsul (2009) 0.79
Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization. Pharmazie (2001) 0.79
Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res (2006) 0.79
Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 0.79
Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India. Clin Rheumatol (2014) 0.79
Evaluation of anti-GERD activity of gastro retentive drug delivery system of itopride hydrochloride. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.79
Mannosylated liposomes for targeted vaccines delivery. Methods Mol Biol (2010) 0.79
Targeted drug delivery systems for pancreatic cancer. J Biomed Nanotechnol (2014) 0.79
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm (2009) 0.79
Implication of gut immunology in the design of oral vaccines. Curr Mol Med (2010) 0.79
Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India. Asian Pac J Allergy Immunol (2014) 0.79
Synthetic peptides: a modern approach to vaccination. Indian J Exp Biol (1998) 0.79
Potential of nanocarriers in genetic immunization. Recent Pat Drug Deliv Formul (2008) 0.78
Targeted intracellular delivery of therapeutics: an overview. Pharmazie (2007) 0.78
Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery. Curr Med Chem (2007) 0.78
Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation. Int J Pharm (2006) 0.78
Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat (2010) 0.78
Organogel-based system for transdermal delivery of propranolol. J Microencapsul (1994) 0.78
Autoimmune pancreatitis: a report from India. JOP (2010) 0.78
Usefulness of testicular fine needle aspiration cytology in cases of infertility. Indian J Pathol Microbiol (2007) 0.78